Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
457.00    -2.60 (-0.57%)
Bid:
456.60
Ask:
456.90
Spread: 0.30 (0.066%)
Market Cap: £5.70b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Financing Update

4 Aug 2020 07:00

RNS Number : 0505V
Melrose Industries PLC
04 August 2020
 

MELROSE INDUSTRIES PLC

 

4 August 2020

 

 

FINANCING UPDATE

 

Melrose Industries PLC ("Melrose" or the "Group") today issues an update on financing.

 

Following the trading updates on 30 March 2020 and 22 July 2020, Melrose has now agreed amended arrangements with its banking syndicate including improved financial covenants to 31 December 2022. Beyond that date the Group reverts to the original covenants for the balance of the facilities' term. These amendments cover all the Group's primary borrowing arrangements that contain financial covenants.

 

The Group's committed c.£3.2 billion revolving credit facility is repayable in January 2023 and the Group's committed term loan of c.£0.9 billion can be extended to April 2024 at Melrose's option. In addition to these committed banking lines the Group has two bonds: a £450 million bond maturing in September 2022 and a £300 million bond maturing in May 2032, neither of which contain financial covenants.

 

Melrose is grateful for the continued support of its lending banks which means that it has the flexibility it needs to continue to focus on cash generation and adapting the Group to current market conditions. The new financial covenants have been designed to give Melrose considerable headroom and flexibility.

 

There is a modest cash cost to secure this amendment but there is no change to previously agreed interest rate calculations. Melrose has passed its covenant tests for 30 June 2020 and would not in fact have needed the net debt: EBITDA waiver granted previously.

 

The improved financial covenants are shown in the table below:

 

Financial

Covenant

31 December 2020

30 June 2021

31 December 2021

30 June 2022

31 December 2022

Net debt :EBITDA

Waiver*

Waiver

5.25x**

4.75x**

4.0x**

EBITDA :Net finance charges

2.5x

3.0x

3.0x

3.25x

4.0x

*Announced on 30 March 2020

**Subject to downward adjustments upon certain material disposals

 

Following 31 December 2022, the financial covenants revert to 3.5x (for net debt: EDITDA) and remain at 4x (for EBITDA: net finance charges).

 

 

 

Simon Peckham, CEO of Melrose Industries PLC, said:

"We have now put in place new amended arrangements with our banks that last until the end of 2022. We thank our banks again for their continued support which gives us the headroom and flexibility to continue to focus on cash generation and adapt the Group as needed. Melrose also retains over £1 billion of cash liquidity. We are confident that we can position the Group to produce good returns for Shareholders."

- ends

 

Enquiries:

 

 

Montfort Communications:

Nick Miles

+44 (0) 20 3514 0897

+44 (0) 7973 130 669

miles@montfort.london

Charlotte McMullen

+44 (0) 20 3514 0897

+44 (0) 7921 881 800

mcmullen@montfort.london

Melrose Investor Relations:

+44 (0) 7974 974690

ir@melroseplc.net

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEZLBBBVLXBBV
Date   Source Headline
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSHolding(s) in Company
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:37 amRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20255:08 pmRNSNotice of AGM
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20252:43 pmRNSNotification of Transactions of Persons
24th Mar 20257:00 amRNSTransaction in Own Shares; Miscellaneous
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSFINAL RESULTS
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20253:10 pmRNSPUBLIC OPENING POSITION DISCLOSURE
12th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.